| scholarly article | Q13442814 |
| P50 | author | Ralph H. Hruban | Q21063634 |
| Charles J Yeo | Q96191880 | ||
| Raheela Ashfaq | Q114316683 | ||
| N Tjarda van Heek | Q114398786 | ||
| Grace L Shen-Ong | Q114439494 | ||
| Michael A. Hollingsworth | Q115598791 | ||
| Christine A Iacobuzio-Donahue | Q58327762 | ||
| Anirban Maitra | Q63019787 | ||
| Michael Goggins | Q63021511 | ||
| P2093 | author name string | Scott E Kern | |
| John L Cameron | |||
| Karin Berg | |||
| Kimberly Walter | |||
| Renee Meyer | |||
| P2860 | cites work | Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands | Q22008687 |
| CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells | Q24291469 | ||
| Impairment of bile salt-dependent lipase secretion in human pancreatic tumoral SOJ-6 cells | Q28139134 | ||
| Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation | Q28141319 | ||
| cDNA cloning, expression pattern, genomic structure and chromosomal location of RAB6KIFL, a human kinesin-like gene | Q28144158 | ||
| Cancer statistics, 2001 | Q28189339 | ||
| The molecular interactions of heat shock protein 47 (Hsp47) and their implications for collagen biosynthesis | Q28191029 | ||
| Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein | Q28240208 | ||
| Human Trop-2 is a tumor-associated calcium signal transducer | Q28272535 | ||
| Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells | Q28280512 | ||
| Expression of a candidate ataxia-telangiectasia group D gene in cultured fibroblast cell lines and human tissues | Q28287375 | ||
| S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles | Q29620465 | ||
| Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). | Q30781823 | ||
| Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer | Q30809756 | ||
| Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. | Q30991221 | ||
| Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. | Q31037582 | ||
| Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer | Q31833417 | ||
| Neutrophil gelatinase-associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression | Q33873179 | ||
| cDNA cloning of a novel bHLH-PAS transcription factor superfamily gene, BMAL2: its mRNA expression, subcellular distribution, and chromosomal localization | Q33915836 | ||
| Tumor therapy with targeted atomic nanogenerators | Q34102138 | ||
| AML1/CBFbeta transcription complex: its role in normal hematopoiesis and leukemia | Q34257991 | ||
| Integrin signaling revisited | Q34446298 | ||
| Location, location, location: membrane targeting directed by PX domains | Q34453921 | ||
| Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. | Q34514616 | ||
| Exploring the host desmoplastic response to pancreatic carcinoma: gene expression of stromal and neoplastic cells at the site of primary invasion | Q35788695 | ||
| Amplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer | Q35809752 | ||
| p202, an interferon-inducible protein, mediates multiple antitumor activities in human pancreatic cancer xenograft models. | Q40683219 | ||
| Invasion-specific genes in malignancy: serial analysis of gene expression comparisons of primary and passaged cancers. | Q40716089 | ||
| Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines | Q40783622 | ||
| Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line | Q40962841 | ||
| Cationic trypsinogen produced by human pancreatic ductal cancer has the characteristics of spontaneous activation and gelatinolytic activity in the presence of proton. | Q40988497 | ||
| Localization of GTPase-activating protein-(GAP) like immunoreactivity in mouse cerebral regions | Q42472692 | ||
| Development and characterization of a cytokine-secreting pancreatic adenocarcinoma vaccine from primary tumors for use in clinical trials. | Q42818041 | ||
| Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation | Q43719938 | ||
| Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: implications for gene therapy | Q43773454 | ||
| Enhanced pancreatic tumor regression by a combination of adenovirus and retrovirus-mediated delivery of the herpes simplex virus thymidine kinase gene | Q45747423 | ||
| Expression of a candidate ataxia-telangieetasia group D gene in cultured fibroblast cell lines and human tissues | Q47682236 | ||
| Amplification of HER-2/neu and topoisomerase IIalpha in primary and metastatic breast cancer. | Q49230662 | ||
| Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. | Q54069950 | ||
| Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. | Q54085358 | ||
| Micromechanics and ultrastructure of actin filament networks crosslinked by human fascin: a comparison with alpha-actinin. | Q55034914 | ||
| TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system | Q60609528 | ||
| Balance of expression of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in chronic pancreatitis | Q60609552 | ||
| CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma | Q71690149 | ||
| Induction of platelet‐derived growth factor A and B chains and over‐expression of their receptors in human pancreatic cancer | Q72036047 | ||
| Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells | Q72655848 | ||
| Duct epithelial cells cultured from human pancreas processed for transplantation retain differentiated ductal characteristics | Q73803440 | ||
| Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold | Q73858077 | ||
| Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas | Q73881726 | ||
| Identifying markers for pancreatic cancer by gene expression analysis | Q74263354 | ||
| Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression | Q77464625 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| P304 | page(s) | 1239-1249 | |
| P577 | publication date | 2002-04-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Discovery of novel tumor markers of pancreatic cancer using global gene expression technology | |
| P478 | volume | 160 |
| Q38723957 | "NextGen" Biologics: Bispecific Antibodies and Emerging Clinical Results |
| Q35304445 | A multistep high-content screening approach to identify novel functionally relevant target genes in pancreatic cancer |
| Q39554498 | A potent and selective inhibitor of KIAA1363/AADACL1 that impairs prostate cancer pathogenesis |
| Q33992146 | A six-gene signature predicts survival of patients with localized pancreatic ductal adenocarcinoma |
| Q37497757 | Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma |
| Q39888180 | Adenylate cyclase-associated protein 1 overexpressed in pancreatic cancers is involved in cancer cell motility |
| Q37263038 | Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors |
| Q38089806 | Applications of microarray technology to pancreatic cancer research and drug development |
| Q33531856 | Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality. |
| Q28276398 | Biomarker discovery from pancreatic cancer secretome using a differential proteomic approach |
| Q28834154 | Bioorthogonal labeling cell-surface proteins expressed in pancreatic cancer cells to identify potential diagnostic/therapeutic biomarkers |
| Q35017547 | CD109 Overexpression in Pancreatic Cancer Identified by Cell-Surface Glycoprotein Capture |
| Q31121505 | Characterization of gene expression in mucinous cystic neoplasms of the pancreas using oligonucleotide microarrays |
| Q39842549 | Characterizing DNA methylation patterns in pancreatic cancer genome. |
| Q90262599 | Chrysin enhances anticancer drug-induced toxicity mediated by the reduction of claudin-1 and 11 expression in a spheroid culture model of lung squamous cell carcinoma cells |
| Q42759235 | Claudin-1 required for HCV virus entry has high potential for phosphorylation and O-glycosylation |
| Q46915043 | Clinical utility of quantitative RT-PCR targeted to alpha1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer |
| Q35588895 | Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses |
| Q36344287 | Comprehensive Dissection of Transcriptome Data and Regulatory Factors in Pancreatic Cancer Cells. |
| Q42053166 | CpG island methylation profile of pancreatic intraepithelial neoplasia |
| Q40447853 | D-TMPP: a novel androgen-regulated gene preferentially expressed in prostate and prostate cancer that is the first characterized member of an eukaryotic gene family. |
| Q85995613 | Development of a cytokine-modified allogeneic whole cell pancreatic cancer vaccine |
| Q38311218 | Differential expression of insulin-like growth factor binding protein-5 in pancreatic adenocarcinomas: identification using DNA microarray |
| Q51488757 | Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens. |
| Q42721594 | Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas. |
| Q38945099 | Down regulated expression of Claudin-1 and Claudin-5 and up regulation of β-catenin: association with human glioma progression |
| Q35099833 | Down-regulation of nicotinamide N-methyltransferase induces apoptosis in human breast cancer cells via the mitochondria-mediated pathway |
| Q39690173 | Effects of small interfering RNAs targeting fascin on human esophageal squamous cell carcinoma cell lines |
| Q24813318 | Evaluation of the similarity of gene expression data estimated with SAGE and Affymetrix GeneChips |
| Q28185685 | Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays |
| Q53301032 | Expression of PSCA, PIWIL1 and TBX2 and its correlation with HPV16 infection in formalin-fixed, paraffin-embedded cervical squamous cell carcinoma specimens. |
| Q24337345 | Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer |
| Q81370836 | Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways |
| Q37190226 | Expression profile and prognostic value of NNMT in patients with pancreatic cancer |
| Q33280569 | Fascin overexpression in intraductal papillary mucinous neoplasms (adenomas, borderline neoplasms, and carcinomas) of the pancreas, correlated with increased histological grade |
| Q92826260 | Ferlin Overview: From Membrane to Cancer Biology |
| Q36899872 | Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival |
| Q35115628 | Gene Expression in Neoplasms of the Pancreas: Applications to Diagnostic Pathology |
| Q31156199 | Gene expression alterations in the non-neoplastic parenchyma adjacent to infiltrating pancreatic ductal adenocarcinoma |
| Q94332166 | Gene expression profile after cardiopulmonary bypass and cardioplegic arrest |
| Q38294269 | Gene expression profiles in primary pancreatic tumors and metastatic lesions of Ela-c-myc transgenic mice |
| Q51599172 | Gene expression profiles of microdissected pancreatic ductal adenocarcinoma. |
| Q35094629 | Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas |
| Q30887318 | Gene expression profiling in islet biology and diabetes research |
| Q34928555 | Gene expression profiling of microdissected pancreatic ductal carcinomas using high-density DNA microarrays |
| Q36032931 | Gene overexpression in pancreatic adenocarcinoma: diagnostic and therapeutic implications |
| Q37772497 | Gene-expression profiling in pancreatic cancer |
| Q24798750 | Genetic alteration and gene expression modulation during cancer progression |
| Q34589293 | Genetics and pathology of pancreatic cancer |
| Q31041732 | Genome-wide cDNA microarray analysis of gene expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection |
| Q35140486 | Genomics and the search for novel biomarkers in toxicology |
| Q42147260 | Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer |
| Q36944033 | High expression of TROP2 correlates with poor prognosis in pancreatic cancer. |
| Q40490949 | High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer |
| Q36326330 | Identification and characterization of the gene expression profiles for protein coding and non-coding RNAs of pancreatic ductal adenocarcinomas |
| Q40273975 | Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples |
| Q52789821 | Identification of candidate miRNA biomarkers for pancreatic ductal adenocarcinoma by weighted gene co-expression network analysis. |
| Q28238147 | Identification of maspin and S100P as novel hypomethylation targets in pancreatic cancer using global gene expression profiling |
| Q35791572 | Identification of novel cellular targets in biliary tract cancers using global gene expression technology |
| Q24656609 | Independent prognostic value of fascin immunoreactivity in stage I nonsmall cell lung cancer |
| Q47433524 | Independent value of fascin immunoreactivity for predicting lymph node metastases in typical and atypical pulmonary carcinoids. |
| Q58689165 | Investigation of Archived Formalin-Fixed Paraffin-Embedded Pancreatic Tissue with Whole-Genome Gene Expression Microarray |
| Q35576601 | Long noncoding intronic RNAs are differentially expressed in primary and metastatic pancreatic cancer |
| Q35627068 | Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma |
| Q28188395 | Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast |
| Q37620679 | Metabolism addiction in pancreatic cancer |
| Q34082610 | MicroRNA alterations of pancreatic intraepithelial neoplasias |
| Q35639853 | Microarray-based gene expression profiling in pancreatic ductal carcinoma: status quo and perspectives |
| Q38350940 | Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent |
| Q37614592 | Molecular changes in pancreatic cancer |
| Q57422493 | Molecular diagnostics in pancreatic cancer |
| Q36485336 | Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts |
| Q36829524 | Molecular genetics of pancreatic intraepithelial neoplasia |
| Q53359744 | Molecular imaging of prostate cancer. |
| Q37081461 | Molecular markers of pancreatic cancer: development and clinical relevance |
| Q47620397 | Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray |
| Q41096139 | NMDA receptors are important regulators of pancreatic cancer and are potential targets for treatment |
| Q30489770 | New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. |
| Q90216387 | Nicotinamide N‑methyltransferase induces the proliferation and invasion of squamous cell carcinoma cells |
| Q73614651 | Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis |
| Q33391858 | Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. |
| Q54422958 | Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. |
| Q26825644 | Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing |
| Q99567378 | N‑glycosylation and receptor tyrosine kinase signaling affect claudin‑3 levels in colorectal cancer cells |
| Q36124027 | Osteopontin expression is associated with improved survival in patients with pancreatic adenocarcinoma |
| Q30797702 | Overexpressed Claudin-1 Can Be Visualized Endoscopically in Colonic Adenomas In Vivo |
| Q33234488 | Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma |
| Q35032539 | Overexpression of COL11A1 by cancer-associated fibroblasts: clinical relevance of a stromal marker in pancreatic cancer |
| Q36308123 | Overexpression of annexin 1 in pancreatic cancer and its clinical significance |
| Q38774676 | Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma |
| Q92715653 | Overexpression of trophoblast cell surface antigen 2 is associated with BRAF V600E mutation and aggressive behavior in papillary thyroid cancer |
| Q37104978 | PSCA and Oct-4 expression in the benign and malignant lesions of gallbladder: implication for carcinogenesis, progression, and prognosis of gallbladder adenocarcinoma |
| Q30483618 | Pancreatic Expression database: a generic model for the organization, integration and mining of complex cancer datasets |
| Q39870304 | Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma. |
| Q24170403 | Pancreatic cancer |
| Q35013204 | Pancreatic cancer biology and genetics |
| Q38354856 | Pancreatic cancer: diagnosis and treatments |
| Q37125627 | Pancreatic carcinogenesis |
| Q34526464 | Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality |
| Q41859957 | Poly(A) RT-PCR measurement of diagnostic genes in pancreatic juice in pancreatic cancer |
| Q54391141 | Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. |
| Q37448935 | Prognostic signature for pancreatic cancer: are we close? |
| Q37186552 | Prostate stem cell antigen: a prospective therapeutic and diagnostic target |
| Q40295403 | Proteomic analysis of primary cell lines identifies protein changes present in renal cell carcinoma |
| Q36026306 | Proteomic profiling of pancreatic cancer for biomarker discovery |
| Q53620234 | Quantitative proteomic profiling of pancreatic cancer juice. |
| Q30534663 | Rapid characterization of candidate biomarkers for pancreatic cancer using cell microarrays (CMAs). |
| Q58714472 | Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem |
| Q36297522 | Role of adjuvant therapy in the management of pancreatic cancer |
| Q35170428 | Role of tissue stroma in cancer cell invasion |
| Q47806512 | Screening of genes specifically activated in the pancreatic juice ductal cells from the patients with pancreatic ductal carcinoma |
| Q51799739 | Serum levels of nicotinamide N-methyltransferase in patients with lung cancer. |
| Q40070727 | Stat3 up-regulates expression of nicotinamide N-methyltransferase in human cancer cells |
| Q33862088 | Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer |
| Q36685675 | Target discovery and validation in pancreatic cancer |
| Q35062469 | The OSBP-related proteins: a novel protein family involved in vesicle transport, cellular lipid metabolism, and cell signalling. |
| Q47866664 | The Role of Drebrin in Cancer Cell Invasion |
| Q37302556 | The claudin family of proteins in human malignancy: a clinical perspective |
| Q40603608 | The efficacy of tyrosine kinase inhibitors on human pancreatic cancer cell lines |
| Q37817143 | The pancreatic cancer proteome - recent advances and future promise |
| Q36542828 | The role of epigenetic alterations in pancreatic cancer |
| Q34476583 | Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma |
| Q38957238 | Universal antibody conjugation to nanoparticles using the Fcγ receptor I (FcγRI): quantitative profiling of membrane biomarkers |
Search more.